You can’t discuss healthcare reform without talking about healthcare insurance exchanges. Certainly they play a central role in the Affordable Care Act, and the focus on enrollment has become an annual industry ritual. But there’s another healthcare exchange, centered around molecular diagnostics, that you might not have heard about. Drug Discovery News recently featured it in detail as a commentary by Doug Moeller, MD, Medical Director for McKesson Health Solutions.
Dr. Moeller discusses how the number of molecular diagnostic tests is growing faster than payers and providers can manage, and how a cloud-based diagnostics exchange can help them uniquely identify each test, evaluate the clinical utility, accelerate new tests to market, and speed reimbursement.